Abstract:BackgroundHypertension is a major contributor to the global disease burden of cardiovascular and cerebrovascular disease. The aim of this study was to determine demographic and clinical factors associated with adherence to antihypertensive medication.MethodsFrom August 2012 to February 2015, we recruited 1,523 Korean patients with hypertension who visited family physicians. The study was conducted in 24 facilities located in urban and metropolitan areas. Of these facilities, two were primary care clinics and 2… Show more
“…The current study shows that, participants who were 64 and below years of age had higher level of treatment compliance compared to those with 65 and above years of age. These results are comparable to those reported from the study done in North America and Korea, reported older age showed association with treatment compliance [19,20]. The possible explanation of these results might be the truth that, the young people have higher income since they are able to work and thus can afford to buy medications than older people.…”
Section: Discussionsupporting
confidence: 87%
“…Our findings showed compliance was higher than that of study conducted in Mumbai, reported 39.4% were compliant to their treatment [17]. The compliance was lower than that reported to the previous study in Korea and India [18,19]. The possible reason for the discrepancy observed could be explained by the types of hospitals included in our study, we included district hospitals, where participants attended are average Tanzanian compared to participants enrolled in the study conducted at Korea and India whom were from tertial hospitals with higher income and education, this could account for the difference observed.…”
Section: Discussioncontrasting
confidence: 74%
“…Distribution of participants by reasons of not complying with antihypertensive medication were determined, the reasons were stopping medication due to; cost of the medications, fear of the side effect [19,20], feeling well (asymptomatic), avoiding addiction of drugs [18] and use of traditional medicine [21].…”
Background Hypertension is one of the most important cardiovascular risk factors; but compliance to anti-hypertensive medications remains to be a public health challenge worldwide. Health belief model have been used to explain adoption of preventive measures to health problems. This study used the health belief model as a framework to explain the compliance to anti-hypertensive drugs among elderly hypertensive patients. The study aimed at finding the influence of health belief model in treatment compliance among elderly hypertensive patients in three district hospitals in Dar es Salaam, Tanzania. Methods We conducted an analytical cross- sectional study in three District hospitals in Dar es Salaam Region. We included patients who were on antihypertensive medications. Simple random sampling was used to enrol study participants. Data were collected using structured questionnaires. Data were analysed using SPSS. Frequency distribution and Multivariate analysis was done using Linear Multiple Regression to identify variables which are strongest predictor of treatment compliance among variables of Health Believe Model. Results: A total of 135 participants were enrolled, 56% were compliant to treatment. Multiple linear regression was used to operationalize the Health Belief Model with treatment compliance being dependant variable. The predictor variables were perceived benefit, perceived barriers and cues to action. Multivariate analysis indicated significant model fit for the data (F = 11.19 and P value < 0.001). The amount of variance in treatment compliance that is explained by the predictors is 30.3% (R² = 0.303) with perceived barrier being the strongest predictor of treatment compliance (β = -0.477; p < 0.001). A negative beta coefficient indicates a negative association between perceived barriers and treatment compliance. Other predictor variables were not statistically associated with treatment compliance. Conclusion: The study showed that almost half of study participants had hypertensive treatment compliance, with the use of health believe model the important strongest variable was perceived barrier to treatment. An innovative strategy on improving patients’ perception of barrier to treatment is recommended to increase treatment compliance. Key words: Hypertension, Treatment compliance, lifestyle
“…The current study shows that, participants who were 64 and below years of age had higher level of treatment compliance compared to those with 65 and above years of age. These results are comparable to those reported from the study done in North America and Korea, reported older age showed association with treatment compliance [19,20]. The possible explanation of these results might be the truth that, the young people have higher income since they are able to work and thus can afford to buy medications than older people.…”
Section: Discussionsupporting
confidence: 87%
“…Our findings showed compliance was higher than that of study conducted in Mumbai, reported 39.4% were compliant to their treatment [17]. The compliance was lower than that reported to the previous study in Korea and India [18,19]. The possible reason for the discrepancy observed could be explained by the types of hospitals included in our study, we included district hospitals, where participants attended are average Tanzanian compared to participants enrolled in the study conducted at Korea and India whom were from tertial hospitals with higher income and education, this could account for the difference observed.…”
Section: Discussioncontrasting
confidence: 74%
“…Distribution of participants by reasons of not complying with antihypertensive medication were determined, the reasons were stopping medication due to; cost of the medications, fear of the side effect [19,20], feeling well (asymptomatic), avoiding addiction of drugs [18] and use of traditional medicine [21].…”
Background Hypertension is one of the most important cardiovascular risk factors; but compliance to anti-hypertensive medications remains to be a public health challenge worldwide. Health belief model have been used to explain adoption of preventive measures to health problems. This study used the health belief model as a framework to explain the compliance to anti-hypertensive drugs among elderly hypertensive patients. The study aimed at finding the influence of health belief model in treatment compliance among elderly hypertensive patients in three district hospitals in Dar es Salaam, Tanzania. Methods We conducted an analytical cross- sectional study in three District hospitals in Dar es Salaam Region. We included patients who were on antihypertensive medications. Simple random sampling was used to enrol study participants. Data were collected using structured questionnaires. Data were analysed using SPSS. Frequency distribution and Multivariate analysis was done using Linear Multiple Regression to identify variables which are strongest predictor of treatment compliance among variables of Health Believe Model. Results: A total of 135 participants were enrolled, 56% were compliant to treatment. Multiple linear regression was used to operationalize the Health Belief Model with treatment compliance being dependant variable. The predictor variables were perceived benefit, perceived barriers and cues to action. Multivariate analysis indicated significant model fit for the data (F = 11.19 and P value < 0.001). The amount of variance in treatment compliance that is explained by the predictors is 30.3% (R² = 0.303) with perceived barrier being the strongest predictor of treatment compliance (β = -0.477; p < 0.001). A negative beta coefficient indicates a negative association between perceived barriers and treatment compliance. Other predictor variables were not statistically associated with treatment compliance. Conclusion: The study showed that almost half of study participants had hypertensive treatment compliance, with the use of health believe model the important strongest variable was perceived barrier to treatment. An innovative strategy on improving patients’ perception of barrier to treatment is recommended to increase treatment compliance. Key words: Hypertension, Treatment compliance, lifestyle
“…These significant predictors included the following: age (OR, 1.04; derstanding about the complications of A-HTNM, lack of social support, poor physician-patient relationship, and health care support affect adherence in different populations. 5,7,[23][24][25] Addressing these factors is very important for successful control and management of HTN. To the best of our knowledge, this is the first study to investigate adherence to A-HTNM and its associated factors among HTN patients attending primary health care centers in the Gaza Strip.…”
Section: Relationship Between Adherence Status and Predictorsmentioning
confidence: 99%
“…However, this finding is consistent with those of several other studies. 13,23,24) One reason for this finding could be that patients taking two or more pills recognize the severity of their disease and hence become more attentive to their treatment. In addition, taking multiple pills probably helped them avoid forgetting their medications.…”
Section: Relationship Between Adherence Status and Predictorsmentioning
Background: This study aimed to estimate the prevalence of and determine the factors associated with antihypertensive medication (A-HTNM) non-adherence among hypertension care seekers attending primary health clinics in the Gaza Strip. Methods: A cross-sectional survey was conducted as the recruitment phase of a clustered randomized controlled trial including 538 participants. The participants were randomly selected from 10 primary health care centers by two-stage cluster random sampling. A structured questionnaire was used to collect data through face-to-face interview. The questionnaire was developed based on the World Health Organization determinants for medication non-adherence and the Health Belief Model. The main outcomes of this study were the prevalences of A-HTNM non-adherence and its associated factors. Adherence status was assessed using the eight-item Morisky Self-Report Medication Adherence Scale. Data were analyzed by STATA ver. 14.0 (Stata Corp., College Station, TX, USA) using a standard complex survey, accounting for unresponsiveness and the clustering sampling approach. Results: The overall prevalence of A-HTNM non-adherence was 65.8% (95% confidence interval [CI], 59.2-71.8). Among all studied predictors, only self-efficacy of participants (odds ratio [OR], 3.8; 95% CI, 1.79-2.84) and social support (OR, 2.26; 95% CI, 2.82-5.11) remained significantly associated with A-HTNM non-adherence after adjusting for age, education level, number and frequency of A-HTNM doses per day, and comorbidities. Conclusion: The high prevalence of non-adherence highlights the need for serious intervention to enhance the adherence rate among hypertension patients. The associated factors can be considered when developing appropriate interventions.
Background: Hypertension and its associated complications are one of the leading causes of morbidity and mortality in Asia. Racial disparities in terms of treatment outcomes among hypertension patients have been reported in literature with Asian patients resulting in poorer treatment outcomes. Non-adherence to antihypertensive therapy is frequently associated with poor treatment outcomes.
Aim of the Review:The aim of this review was to estimate the prevalence of non-adherence to antihypertensive medications among patients with hypertension residing in Asia.Method: PubMed, Google Scholar, MEDLINE, Embase, Scopus, CINHAL and Cochrane library were searched for studies published between 2000 and 2019 involving hypertensive patients. Studies investigating the prevalence of medication non-adherence in Asian countries, rated either good or fair on National Institute of Health quality assessment tool and published in English language were included in our review. Data were extracted by one author and checked by another using a structured and pilot-tested data extraction sheet. A random-effects meta-analysis was performed using STATA version 14.3®.
Results:Sixty-Seven studies from 22 Asian countries including 2,532,582 hypertensive patients were included. Mean (±SD) age of participants was 58(±6) years. Overall, the estimated prevalence of non-adherence to antihypertensive medication in Asia was 48% (95% CI: 41-54, P=0.001). The rate of non-adherence was higher among females 49% (95% CI: 41-56, P=0.001) compared to males 47% (95% CI: 40-53, P=0.001). As per the region, the highest prevalence of non-adherence was found in South Asia 48% (95% 44-51, P=0.877) followed by East Asia 45% (31-59, P=0.001) and the Middle East 41 (95% 30-52, P=0.001). Similarly, higher rate of nonadherence was observed in low and lower middle-income countries i.e. 50% (95% CI: 47-54, P=0.220) as compare to upper-middle and high-income countries i.e. 37% (95% CI: 25-49, P=0.001) and 44% (29-59, P=0.001) respectively.
Conclusion:The prevalence of non-adherence to antihypertensive medication is high in Asia. This may partly explain poor treatment outcomes and incidence of higher mortality rate in Asia frequently reported in the literature. There is a need to implement appropriate policies and clinical practices to improve medication adherence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.